Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 12:00 pm Sale | 13G | 89BIO INC ETNB | BIOTECHNOLOGY VALUE FUND L P | 3,521,126 6.5% | -376,874 (-9.67%) | View |
| 2023-02-09 08:31 am Purchase | 13G | 89BIO INC ETNB | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,692,549 7.22% | 1,002,549 (+37.27%) | View |
| 2023-01-26 4:40 pm Sale | 13D | 89BIO INC ETNB | ORBIMED ADVISORS LLC | 1,504,436 3.2% | -325,000 (-17.77%) | View |
| 2022-12-29 4:15 pm Purchase | 13G | 89BIO INC ETNB | Cormorant Asset Management LP | 2,550,000 5.48% | 2,550,000 (New Position) | View |
| 2022-10-21 06:03 am Purchase | 13D | 89BIO INC ETNB | RA CAPITAL MANAGEMENT L.P. | 9,376,402 19.9% | 1,570,233 (+20.12%) | View |
| 2022-08-12 5:28 pm Purchase | 13G | 89BIO INC ETNB | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,690,000 6.8% | 2,690,000 (New Position) | View |
| 2022-07-11 5:03 pm Purchase | 13G | 89BIO INC ETNB | BIOTECHNOLOGY VALUE FUND L P | 3,898,000 9.99% | 3,898,000 (New Position) | View |
| 2022-07-08 5:13 pm Purchase | 13G | 89BIO INC ETNB | GREAT POINT PARTNERS LLC | 2,100,000 5.29% | 2,100,000 (New Position) | View |
| 2022-07-07 09:24 am Purchase | 13G | 89BIO INC ETNB | Deep Track Capital LP | 4,331,499 9.99% | 4,331,499 (New Position) | View |
| 2022-07-06 5:25 pm Purchase | 13D | 89BIO INC ETNB | RA CAPITAL MANAGEMENT L.P. | 7,806,169 19.9% | 2,840,400 (+57.20%) | View |
| 2022-07-05 4:30 pm Sale | 13D | 89BIO INC ETNB | ORBIMED ADVISORS LLC | 1,829,436 4.7% | -35,285 (-1.89%) | View |
| 2022-06-10 10:14 am Sale | 13G | 89BIO INC ETNB | WELLINGTON MANAGEMENT GROUP LLP | 0 0% | -2,150,475 (Position Closed) | View |
| 2022-02-14 06:11 am Sale | 13G | 89BIO INC ETNB | Nussbaum Ran | 827,701 4.1% | -194,753 (-19.05%) | View |
| 2022-02-07 5:15 pm Sale | 13D | 89BIO INC ETNB | Longitude Capital Partners III LLC | 1,222,733 6% | -531,117 (-30.28%) | View |
| 2022-01-10 08:37 am Purchase | 13G | 89BIO INC ETNB | WELLINGTON MANAGEMENT GROUP LLP | 2,150,475 10.6% | 885,564 (+70.01%) | View |
| 2021-06-04 4:32 pm Purchase | 13D | 89BIO INC ETNB | RA CAPITAL MANAGEMENT L.P. | 4,965,769 24.8% | 229,555 (+4.85%) | View |
| 2021-02-09 10:20 am Sale | 13G | 89BIO INC ETNB | Nussbaum Ran | 1,022,454 5.1% | -112,217 (-9.89%) | View |
| 2021-02-04 11:19 am Purchase | 13G | 89BIO INC ETNB | WELLINGTON MANAGEMENT GROUP LLP | 1,264,911 6.36% | 341,912 (+37.04%) | View |
| 2020-11-25 4:32 pm Sale | 13D | 89BIO INC ETNB | Longitude Capital Partners III LLC | 1,753,850 8.8% | -847,027 (-32.57%) | View |
| 2020-09-23 5:00 pm Sale | 13D | 89BIO INC ETNB | ORBIMED ADVISORS LLC | 1,864,721 9.4% | -137,500 (-6.87%) | View |